Date published: 2025-10-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

HEXDC Inhibitors

HEXDC inhibitors are a class of chemical compounds that target and inhibit the activity of the enzyme hexadecanoyl-CoA dehydrogenase (HEXDC). HEXDC is an enzyme primarily involved in the metabolism of long-chain fatty acids, specifically facilitating the oxidation of hexadecanoyl-CoA, a saturated long-chain fatty acyl-CoA derivative, during fatty acid beta-oxidation. This enzyme plays a crucial role in maintaining cellular energy balance, particularly in tissues that rely heavily on fatty acid oxidation for their energy needs. By inhibiting HEXDC, these inhibitors effectively block a critical step in the breakdown of long-chain fatty acids, disrupting the normal metabolic pathways that depend on this process.

The molecular mechanisms underlying HEXDC inhibition involve binding to the active site of the enzyme, preventing the dehydrogenation of hexadecanoyl-CoA. This action leads to the accumulation of long-chain fatty acyl-CoA molecules, altering metabolic flux and shifting the balance toward alternative energy sources. HEXDC inhibitors are of particular interest in research because of their potential to modulate metabolic processes in various cellular environments. The structural diversity of these inhibitors allows for precise control over enzyme activity, making them useful for studies aimed at understanding fatty acid metabolism and its regulation. Researchers often investigate the biochemical properties of HEXDC inhibitors, such as their affinity for the enzyme, specificity, and impact on metabolic intermediates, to gain deeper insights into lipid metabolism and energy homeostasis.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Inhibits PI3K/Akt pathway, potentially affecting proteins involved in cell survival and growth.

Triciribine

35943-35-2sc-200661
sc-200661A
1 mg
5 mg
$102.00
$138.00
14
(1)

Inhibits Akt activation, which can affect protein synthesis and cellular metabolism.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

Inhibits MEK, which could impact proteins involved in the MAPK/ERK signaling pathway.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, potentially altering transcription factor activity and apoptosis.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

Inhibits p38 MAPK, which could affect proteins involved in inflammatory responses and stress signals.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits mTOR, which can influence cell growth and protein synthesis.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Inhibits PI3K, potentially impacting a wide range of signaling pathways, including those for growth and survival.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$150.00
$349.00
15
(1)

Inhibits Aurora kinase, which can affect cell cycle progression and mitosis.

Olomoucine

101622-51-9sc-3509
sc-3509A
5 mg
25 mg
$72.00
$274.00
12
(1)

Inhibits cyclin-dependent kinases (CDKs), potentially influencing cell cycle regulation.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$92.00
$260.00
42
(2)

Inhibits CDKs, which could impact the regulation of cell division and transcription.